MHRA-102310-PIP01-26

Key Facts

Active Substance
Active Substance:
  • surabgene lomparvovec
Invented Name
Not yet available
PIP Number MHRA-102310-PIP01-26
Pharmaceutical form(s)
Pharmaceutical form(s):
  • Suspension for injection
Therapeutic area
Therapeutic area:
  • Ophthamology
Conditions / Indications
Conditions / Indications:
  • Treatment of diabetic retinopathy
Route(s) of administration
Route(s) of administration:
  • Suprachoroidal space injection
PIP applicant
Decision Type
Decision Type
W: decision granting a waiver in all age groups for the listed condition(s).
Compliance Check
Compliance Check
No
Compliance Check Decision Date
Compliance Check Procedure Number

Decision Document

Decision Document Decision Document on a Paediatric Investigation Plan (PIP):surabgene lomparvovec.pdf
Published Date 16/07/2026